Athersys, Inc. (ATHXQ)

0.0000 0.00 (0.00%) USD  |  OTCM  |  Aug 31, 16:00
More

Athersys Free Cash Flow

Free Cash Flow Chart

View Free Cash Flow for ATHXQ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Free Cash Flow Data

View and export this data back to 2008. Start Trial.
Date Value
September 30, 2023 -24.71M
June 30, 2023 -31.47M
March 31, 2023 -44.96M
December 31, 2022 -59.35M
September 30, 2022 -68.57M
June 30, 2022 -78.02M
March 31, 2022 -80.69M
December 31, 2021 -77.54M
September 30, 2021 -75.71M
June 30, 2021 -75.53M
March 31, 2021 -67.73M
December 31, 2020 -62.97M
September 30, 2020 -55.57M
June 30, 2020 -43.94M
March 31, 2020 -42.78M
December 31, 2019 -35.90M
September 30, 2019 -30.34M
June 30, 2019 -30.21M
March 31, 2019 -14.49M
December 31, 2018 -14.88M
September 30, 2018 -16.41M
June 30, 2018 -15.14M
March 31, 2018 -24.76M
December 31, 2017 -24.30M
September 30, 2017 -24.40M
Date Value
June 30, 2017 -24.19M
March 31, 2017 -25.29M
December 31, 2016 -12.64M
September 30, 2016 -11.67M
June 30, 2016 -8.75M
March 31, 2016 -7.813M
December 31, 2015 -13.90M
September 30, 2015 -14.66M
June 30, 2015 -17.28M
March 31, 2015 -17.61M
December 31, 2014 -26.09M
September 30, 2014 -24.50M
June 30, 2014 -23.95M
March 31, 2014 -24.38M
December 31, 2013 -23.17M
September 30, 2013 -22.28M
June 30, 2013 -20.19M
March 31, 2013 -18.60M
December 31, 2012 -18.01M
September 30, 2012 -18.84M
June 30, 2012 -19.50M
March 31, 2012 -18.84M
December 31, 2011 -15.08M
September 30, 2011 -13.18M
June 30, 2011 -11.04M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. -75.11M
Oncolytics Biotech, Inc. -26.53M
Sangamo Therapeutics, Inc. -90.46M
Sarepta Therapeutics, Inc. 58.34M
Anixa Biosciences, Inc. -7.117M